SFMN - Oncology
Version Française
English Version
Computation of contact restriction time after targeted radionuclide therapy TRT (Radioprotection)
Results established on 02 May 2026
Mandatory elements to be specified
Radiopharmaceutical::
—
Iodine-131-0%-uptake
Iodine-131-5%-uptake
Iodine-131-25%-uptake
Iodine-131-Benign disease
PSMA-177Lu
PSMA-177Lu 4 cures
PSMA-177Lu 6 cures
Radium-223
NET 177Lu
NET 177Lu 4 cures
Microspheres-90Y
Microspheres-166Ho
Lipiodol-131I
MIBG 131I
Synovectomy-90Y
Synovectomy-186Re
Synovectomy-169Er
to define
Dose rate at 1m at room exit:
µSv/h
Patient size:
*
cm
Effective half-life and scenario adapted to the patient
No
Yes
Effective half-life:
*
d
Duration at X m:
h
Distance X:
m
Duration at 1 m (value required):
h
Distance 1 m:
m
Dosimetric constraint:
mSv
Benign thyroid disorders:
No
Yes
Activity administered:
MBq
Pathology:
Autonomous nodule
Multinodular goitre
Graves’ disease
to be specified
Iodine uptake:
estimated
measured
Iodine uptake:
%
Iodine uptake:
15
25
30
%
Software Version 2.0 (2025-09-02)
Computation of contact restriction time
Retour au CNP-MN